ProCE Banner Activity

Managing Major Depression: Can We Do Better?

Slideset Download

This presentation on managing major depression reviews the unmet needs in major depression as they relate to current treatment strategies, evidence supporting the use of atypical antipsychotics as augmentation therapy in major depression, and evidence-based patient treatment plans based on patient- and disease state–specific characteristics.

Released: August 30, 2022

Expiration: August 29, 2023

No longer available for credit.
Begin Activity

Share

Faculty

Manish K. Jha

Manish K. Jha, MD

Associate Professor of Psychiatry
O'Donnell Clinical Neuroscience Scholar
Center for Depression Research and Clinical Care
UT Southwestern Medical Center
Dallas, Texas

Vladimir Maletic

Vladimir Maletic, MD

Clinical Professor
Department of Psychiatry
USC School of Medicine
Greenville, South Carolina

Greg W. Mattingly

Greg W. Mattingly, MD

Associate Clinical Professor
Department of Psychiatry
Washington University School of Medicine
President
St. Charles Psychiatry Associates
St. Louis, Missouri

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This program is supported by educational grants from:

AbbVie Inc.

Faculty Disclosure

Primary Author

Manish K. Jha, MD

Associate Professor of Psychiatry
O'Donnell Clinical Neuroscience Scholar
Center for Depression Research and Clinical Care
UT Southwestern Medical Center
Dallas, Texas

Manish K. Jha, MDconsultant/advisor/speaker: Boehringer Ingelheim, Eleusis Therapeutics, Guidepoint Global, HC Wainwright & Co., IQVIA, Janssen Global Services, Janssen Research and Development, Vicore Pharma, Medscape/WebMD, Worldwide Clinical Trials, Psychiatry Clinics of North America, Psychiatry and Behavioral Health Learning Network; researcher: Janssen Research and Development, Naviator/Supernus, Neurocrine.

Vladimir Maletic, MD

Clinical Professor
Department of Psychiatry
USC School of Medicine
Greenville, South Carolina

Vladimir Maletic, MD: consultant/advisor/speaker: AbbVie, Alfasigma, Alkermes, Intra-Cellular, Janssen, Lundbeck, Otsuka, Sage, Supernus.

Greg W. Mattingly, MD

Associate Clinical Professor
Department of Psychiatry
Washington University School of Medicine
President
St. Charles Psychiatry Associates
St. Louis, Missouri

Greg W. Mattingly, MD: consultant/advisor/speaker: AbbVie, Acadia, Alkermes, Axsome, Corium, Eisai, Ironshore, Intracellular, Janssen, Lumos Labs, Lundbeck, MedPoint, Neos, Neurocrine, Noven, Otsuka, Redax, Roche, Rhodes, Sage, Skye Therapeutics, Sunovion, Supernus, Takeda, Teva, Trispharma; researcher: AbbVie, Acadia, Alkermes, Akilli, Axsome, Boehringer Ingelheim, Corium, Emalex, Idorsida, Janssen, Karuna, Lumos Labs, Medgenics, NLS-1 Pharma AG, Otsuka, Redax, Relmada, Roche, Sage, Sirtsei, Sunovion, Supernus, Takeda, Teva.